The study assessed the functional properties, microstructural features and sensory characteristics of chokeberry powders obtained by the new fluidised bed jet milling and drying method as compared to other drying methods such as freeze-drying, vacuum drying and convection drying. The new method was based on simultaneously drying and milling plant material which had been subjected to partial air drying at 70 °C prior to this treatment. The technique resulted in the production of good quality fruit powders with high vitamin C and polyphenolic content, as well as high antioxidant activity. Favourable physiochemical characteristics and sensory qualities were also observed together with low water activity. The new fluidized bed jet milling and drying therefore compared very favourably with freeze-drying, vacuum drying and convection drying when considering the content of bioactive substances, physiochemical features and the sensory quality of the prepared powders.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595030 | PMC |
http://dx.doi.org/10.1007/s10068-019-00556-1 | DOI Listing |
Front Physiol
October 2024
Chronobiology and Sleep Laboratory, Department of Physiology, College of Biology, University of Murcia, Mare Nostrum Campus, IUIE, IMIB-Arrixaca, Murcia, Spain.
Introduction: The interplay among sleep patterns, social habits and environmental cues is becoming increasingly more important for public health and wellbeing due to its connection to circadian desynchronization. This paper explores said connections in Spain (which has an official and solar time mismatch), introducing the "Three Times Score" ‒which is based on questions widely used in the field‒ as a complementary tool for exploring the interplay of daily rhythms.
Methods: The questionnaire covers sleep-related habits, social time, and environmental time.
Materials (Basel)
October 2024
Department of Industrial Engineering, University of Padova, 35131 Padova, Italy.
The recent COVID-19 emergency has led to an impressive increase in the production of pharmaceutical vials. This has led to a parallel increase in the amounts of waste glass; manufacturers typically recover material from faulty containers by crushing, giving origin to an unrecyclable fraction. Coarse fragments are effectively reused as feedstock for glass melting; on the contrary, fine powders (<100 microns), contaminated by metal and ceramic particles due to the same crushing operations, are landfilled.
View Article and Find Full Text PDFRev Sci Instrum
November 2024
General Atomics, San Diego, California 92121, USA.
Many current and upcoming laser facilities used to study high-energy-density (HED) physics and inertial fusion energy (IFE) support operating at high rep-rates (HRRs) of ∼0.1-10 Hz, yet many diagnostics, target-fielding strategies, and data storage methods cannot support this pace of operation. Therefore, established experimental paradigms must change for the community to progress toward rep-rated operation.
View Article and Find Full Text PDFMaterials (Basel)
September 2024
Chair of Materials Engineering of Additive Manufacturing, TUM School of Engineering and Design, Technical University of Munich, Freisinger Landstraße 52, 85748 Garching, Germany.
The processing of pure copper (Cu) has been a challenge for laser-based additive manufacturing for many years since copper powders have a high reflectivity of up to 83% of electromagnetic radiation at a wavelength of 1070 nm. In this study, Cu particles were coated with sub-micrometer tungsten (W) particles to increase the laser beam absorptivity. The coated powders were processed by powder bed fusion-laser beam for metals (PBF-LB/M) with a conventional laser system of <300 watts laser power and a wavelength of 1070 nm.
View Article and Find Full Text PDFNat Commun
August 2024
Moderna, Inc., Cambridge, MA, USA.
Primary vaccination with mRNA-1273 (100-µg) was safe and efficacious at preventing coronavirus disease 2019 (COVID-19) in the previously reported, blinded Part A of the phase 3 Coronavirus Efficacy (COVE; NCT04470427) trial in adults (≥18 years) across 99 U.S. sites.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!